Events occurring during the induction and consolidation therapy
| . | Induction . | Consolidation 1 . | Consolidation 2 . | Consolidation 3 . |
|---|---|---|---|---|
| No. of registered patients | 283 | 267 | 258 | 250 |
| Death during treatment | 13 | 0 | 4 | 6 |
| Infection | 1 | 0 | 4 | 6 |
| Bleeding | 9 | 0 | 0 | 0 |
| RA syndrome | 2 | 0 | 0 | 0 |
| Other | 1 | 0 | 0 | 0 |
| Going off study by toxicity | 0 | 3 | 0 | 0 |
| Lost to follow-up | 2 | 6 | 3 | 7 |
| Relapse | 0 | 0 | 1 | 2 |
| Refractory | 1 | 0 | 0 | 0 |
| Stem cell transplantation | 0 | 0 | 0 | 0 |
| No. of completed patients | 267 | 258 | 250 | 235 |
| . | Induction . | Consolidation 1 . | Consolidation 2 . | Consolidation 3 . |
|---|---|---|---|---|
| No. of registered patients | 283 | 267 | 258 | 250 |
| Death during treatment | 13 | 0 | 4 | 6 |
| Infection | 1 | 0 | 4 | 6 |
| Bleeding | 9 | 0 | 0 | 0 |
| RA syndrome | 2 | 0 | 0 | 0 |
| Other | 1 | 0 | 0 | 0 |
| Going off study by toxicity | 0 | 3 | 0 | 0 |
| Lost to follow-up | 2 | 6 | 3 | 7 |
| Relapse | 0 | 0 | 1 | 2 |
| Refractory | 1 | 0 | 0 | 0 |
| Stem cell transplantation | 0 | 0 | 0 | 0 |
| No. of completed patients | 267 | 258 | 250 | 235 |